Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd Say We're Getting Oversold
But I still remember last March-April(2014)
Will it be 2 years without a rally?
Waiting for Q2 data is going to seem like forever.
But it's only 4 months.
So much for double digits, huh?
Let's hope it doesn't get delisted.
Germanwings is a consequence of low pilot wages
Pizza delivery boys make more than new hire
commuter airline pilots.
When you pay highly skilled people this way,
or even if you treat them this way,
good people begin to no longer show up.
Now privacy laws will be relaxed. And it will
become a witch hunt on pilots. There are
enough pilots on anti-anxiety meds to really
frighten the public.
So this is a big can of worms.
And if there is actually a pilot shortage,
it will get worse.
Chalk this up to first greed, then egalitarianism.
Treating highly skilled people the same as any
other employee, or pretending that everyone
is the same, does have consequences.
We're Way Past Half Way Home
We're not in the lab any more.
We're out of the lab, Phase 1 is over !
Haven't been in the lab for quite a while.
The hard science is DONE !
And as luck would have it, phase 1 indicated
that the thing WORKS !
Phase 2 Pivotal -APPROVED !
In both the US and Europe !
Both the FDA and EMA !
This is going to happen this year.
Let's look at some facts.
Post 100:1 Reverse Split 27 Aug 2014
Share Count: 34,393,658
Today Post Phase 1, From 16 Mar 2015 —10K
35,042,363 shares as of March 1, 2015
NO DILUTION !
OCAT is in a new era.
OCAT has:
27Aug2014-Successful Reverse Split
14Oct2014-Successful Phase 1 Lancet
24Nov2014-Successful ATMP from EMA
03Feb2014-Successful John Hefferman VPM
26Feb2015-Successful NSDQ Up List
17Mar2015-Successful EMA/FDA Phase 2 Pivotal
This is Ocata's track record. NOW.
AND THIS LIST IS GETTING LONGER !
Ocata is now working on removing the immunosuppression
drug requirements---To Great Future Benefit if accomplished !!!
This will be the next on this list!
OCAT Manufactures RPE Cells. Hefferman.
OCAT does not inject Stem Cells.
We can, in the laboratory, take the stem cells and turn them into essentially brand new, young, juvenile retinal pigment epithelium and give somebody a fresh layer of these cells that could take them, if they have macular degeneration and say they're 40, 50, 70 years old, for the duration.
(for the duration means for the rest of their life)
Dr. Stephen Schwartz on Charlie Rose show, 4/22/14
http://www.charlierose.com/watch/60378567
This is not 'in the lab' any more!
This is being commercialized by Hefferman.
It' his purpose for being hired.
The phrase ‘turn them into’ - - - means to CHANGE them from Stem Cells
into RPE Cells. THEY ARE NO LONGER STEM CELLS !!!
This is a key point to Ocata’s approach and their IP technology they spent 20 years developing.
It’s WHY Ocata’s RPE Therapy is as safe as it is. RPE Cells, fully differentiated cells,
NO LONGER have the ability to change
PW: We are not a STEM cell company.
PW: We use stem cells as a raw material
to manufacture fully differentiated cells.
In this same television program the story of Cathy,
the first Stargarts patient injected with OCATs RPE Therapy,
is recounted by Cathy herself. It’s about 40 minutes in and
it’s very, very touching.
This is REAL, these are REAL people.
The RPE Therapy is REAL,
it EXISTS,
and it WORKS !
Listen to Cathy.
(I wish someone, could put her snippet on youtube)
http://www.charlierose.com/watch/60378567
Amazing Video of The Future Potential For ONVO
Except the video is from 2009, and the patient had been
treated 10 years! earlier!!!
www.youtube.com/watch?v=9RMx31GnNXY
I like where they are printing directly to the human body.
Under $10 on a $3 stock LOL
That's a bit of an unhelpful range,
but whatever.
This stock is getting less and less over valued,
if that's what it was.
I can't see how the shorts find it as attractive as
when it was higher.
So we will now see how long the shorts want to
stick around.
Especially if there is a more clear understanding
of the contract situation with the flagship product.
80% successful response, doesn't sound like
a bad thing to me.
When a stock gets this low. The plants and structures
almost become significant assets.
That didn't take long to be Wrong
did it?
I'm averaging down here. But it looks
like I'm wrong.
When ThisThing Rallys, it's_Gonna_Be_a_HeartPounder!
It can't keep trading like it's going out of business,
because everyone knows were a quarter away from profits.
The company was spooked into admitting as much,
in the feel good press release.
Looks like a bottom here.
A Partner or JV doesn't Seem Likely NearTerm
PW has stated clearly that they will go it alone
with their flagship RPE product. His reasoning
is the fact that there are only 2000 retina specialists,
and other good reasons as well. market potential,
unmet need, etc
And I think the RPE is the primary focus of the company
for now. Don't forget everything has to go through the FDA.
HOWEVER, OCAT has so many things that COULD be JV'd,
the animal stuff, the platelets, the iMCs, and all of their
processes could be licenced. Ocata will have multiple
wellsprings of income streams bursting out in all
directions.
The RPE therapy will trail blaze a foot path through
the FDA jungle, then everything will quickly stream out.
The SPA is such, good, good, news.
The Shorts are Slapping ONVO like_a_Little_Beeoch
The Nasdaq short data fron Tuesday rose slightly
still at 16 million
How Many Billions of Dollars Can_Dance_on_the Head_of_a_Pin?
This company is configured for hundred dollar oil.
At forty dollar oil, this company will make billions and billions more.
Why isn't the share price at least gradually rising?
Is the market stupid? Or is it insane? Or both.
Comparing OCAT to another Biotech, Reveals Complete Ignorance
of what Ocata has achieved, and what's going on here.
Ocata has done two essential things that sets it apart
from anything before it.
First, Ocata has discovered a way to manufacture RPE cells identical to the cells already in your body. For this to fail in
the future, they would have to 'somehow?' un-discover this.
And this is simply impossible. You cannot un-discover
anything!
And these are not stem cells any longer, so there is no tumor risk. Not stem cells, RPE cells. To talk about tumors is
ignorance and scare talk, that ignores phase 1 data.
SECOND, Ocata has developed a technique for transplanting
these RPE cells into the eye and have them take hold and
flourish and rebuild the bottom layer of the retina. For this
to fail they would have to un-learn what they already know.
And this is not possible.
Let Dr. Anglade explain it.
RoadShow Slide 21
Dr. Anglade: Talking about people with
macular degeneration(Partial Blindness):
Our proposition for these patients is to take a suspension of the pigment epithelia cells and inject them right under the retina.
They[the RPE cells] go and find a place to begin functioning and ultimately...re-establish those connections that are necessary for vision. And allow the patients to re-establish vision.
...Up till now it's been technically challenging to do this, almost essentially impossible. But the first hurdle was to be able to do this, and it's been done.
So what Ocata has done here amounts to discovery and
technique.
THIS IS NOT LIKE ANY OTHER BIOTECH COMPANY BEFORE!
You cannot compare Ocata to anything else in existence.
Because it's a completely new discovery.
The pitter-patter about phase 2 and phase 3 is just so
much drivel. With a phase 2 pivotal, I don't think there
will even be a phase 3.
It's certainly not like a drug, in spite of the FDAs regulatory approach. There's no worry about RPE cells being toxic
to the liver or kidney.
You already have RPE cells in your body!
And it's not comparable to a risky heart transplant.
The RPE layer of the retina is not a major or essential
component of your body. Even if RPE therapy fails
once in while, so what, the patient has lost nothing.
He simply hasn't gained anything.
This is key! This certainly won't work every time. But
who cares? Some patient's eyes will undoubtedly be
un-repairable. But this does NOT take anything away
from RPE therapy!
After phase 1, there is no down side here!
The market will figure this out, eventually.
"Those who are enlightened before the others. Are
condemned to pursue that light. In spite of others."
Christopher Columbus.
This is kind of appropriate.
www.youtube.com/watch?v=Q0iqg2UanEc
The iPSC deal is another Slam Dunk!
Stem Cells are raw material for ALL of OCATs
product lines.
Now they have both eHSCs and iPSCs to manufacture with.
Let's hope the deal boxes out other companies from
eye therapies.
OCAT knows what to do with stem cells. This is what
their entire IP is about.
This is like a construction company that now owns its own
lumber and concrete plant.
Slam Dunk, and the backboard is shattered!
Another step forward fo OCAT.
Everything since the reverse split until now has been absolutely positive!
Gee, Ya Think !
This looks like a blow off bottom
Next tuesday the shorts get reported,
if the number is large, it could mean
the shorts are coming off.
It's normal to take profits, especially
with big profits. The shorts have won big.
But 2014, was a bit lackluster even though
successful for the shorts. It was dead money
for them too in a way.
Now Grandma Yellow has given everyone
a green pasture to trot in and some will gallup.
Next tuesday we'll see.
Oil going to $20 isn't in the market yet. No
one is even considering that it will stay there
for an extended period.
But, I think it will.
I think the Shorts are Coming Off RightNow !
I have no idea how this is being done,
some sort of algorithm, I suppose.
The 19 million shorts have so dried up buying,
and I think what we are seeing is this lack of
buying masking a walk-down, buy back type
of thing that is resulting in net shorts being
removed.
We'll see next week on the finra report.
This is the time to begin the short squeeze,
and the longs are too shell shocked to see it.
Phase 2 Pivotal is a Complete Slam Dunk !
And is very quickly becoming a mere formality.
It looks like PW and team, has coordinated with the
EMA and the FDA, to combine the phase 2 pivotal
trials.
Thus saving time, money, and effort.
This benefits the patients and the shareholders.
Stargarts and dry AMD patients are suffering with no
treatment available, Stargarts being an orphan and
dry AMD approaching an epidemic.
http://ir.ocata.com/press-releases/detail/2754/ocata-therapeutics-receives-regulatory-guidance-from
17 Mar 2015
"We are pleased with the guidance we’ve received from the European Medicines Agency which means that our SMD program can be initiated as a pivotal clinical trial, potentially allowing us to apply for marketing authorization upon its completion,” said Paul K. Wotton, President and Chief Executive Officer of Ocata Therapeutics who added, “As a result of these discussions we plan to enroll a total of approximately 100 patients, including an untreated control arm to more closely match guidance received from FDA. This would harmonize the development approach resulting in a more effective program.”
Ocata previously announced that it has been granted Advanced Therapy Medicinal Product (ATMP) designation for its RPE therapy for macular degeneration. The SMD program has orphan status both in Europe and the US.
THIS IS HUGE-NORMOUS !!!
Obviously, the citizenship of the trial participants makes
no difference to the disease. It's all about the data.
And regardless if the EMA and FDA trials are formally combined,
occur concurrently, or take place one after
the other, it's all a formality, once the very well designed
phase 2 pivotal is underway.
Cowboy 20/40, as I like to call him, achieved his stunning results
in 30 to 60 days, depending on which reporter you choose to follow. This patient was an elderly man whose eyesight had degenerated to worse than 20/400, some say 20/800. Following OCATs RPE treatment, after only 60 days, he had 20/40 vision in his treated eye, and he could ride his horses again. This is wonderful. I call 20/40 vision from worse than 20/400 a cure. You characterize it however you wish.
Q2 injections of the first 20 AMD patients will leave the entire
second half of 2015 to observe the results. These new patients
will be much healthier than the phase 1 patients.
I expect to see 20 examples of Cowboy 20/40, backed up by, before
and after, high resolution imagery showing the repaired RPE layer.
And all this in 30-60 days after injection. This therapy either works
or not after being injected. Because it's living cells, not a drug
that slowly coaxes the body to heal. It's tissue transplantation,
on the cellular lever. This is entirely new and it's brilliant !
It's one milestone reached after another with this company!
2015 is shaping up to be a historic year for our little Ocata.
Founded in 1994, left in the wilderness to suffer and persevere.
And only 20 years later on the brink of unimaginable success.
Nicely done!
Ocata, oh my!
btw, nsdq options !!!
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.21
(b) Phase 2. Phase 2 includes the controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects.
From Wikipedia, the free encyclopedia
A pivotal trial can refer to a clinical trial or study intended to provide evidence for a drug marketing approval,[1] e.g. by the US FDA. Phase III trials are assumed to be pivotal so the phrase is often used for the rare pivotal phase II trials.
7.42 was the high on Jan 2, 2015
Also the high for the year.
I wonder if that's it for the year?
The mar/apr 2014 was a rout from
10.84 down to 5.12, over 50%
So far mar 2015 is down from
6.57 down to 3.99, almost 50%
What will April bring?
What's Mar/Apr 2015 going to look like?
This stock is in a death spiral.
It has an annual mar/apr plunge,
followed by a year long sideways gestation.
March has been a complete collapse.
For All the Quitter Talk About Funding
This last paragraph from page 6 of the current 10K.
Really crystalizes what the company is doing and
how important their work is. There will be no
shortage of funds for a CURE for an orphan status
disease in both Europe and The US.
(10K)
As we continue to manage our clinical trials and expand the indications for which our RPE cell therapy is being investigated, we have also begun to take the steps to define our final product formulation, as well as to lay the early ground work to support appropriate pricing, coverage and reimbursement programs. We believe that our RPE therapy provides pricing justification across all categories of consideration by Medicare, Medicaid, National Health Service (UK) and private payers. Our program related to RPE cell therapy for the treatment of SMD has been granted Orphan Drug status in both the U.S. and Europe, which could accordingly lead to provide regulatory market exclusivity and potential FDA grant opportunities.
(end 10K)
Pages 1 through 6 ought to be read by those who CAN read
and are capable of even rudimentary understanding.
It very clearly explains that OCATs therapy is a CELL
therapy, that is beyond conventional drugs.
First the SPA, Then Breakthrough Status
It will then be on to the first 20 patients for Stargarts.
It will be interesting to see how these first 20 are
injected, if they do them all at once or as before,
one then wait, then again.
If they do them all at once, this will mean an accelerated
approach is being taken to collect the data and wrap
this up.
The RPE therapy is not a drug, it's an injection of living
cells, that amounts to a retina transplant. There is no
controversy about this. This drug trial will be like none
before it.
The Drop To 3.99 May Have Spooked the_Shorts.
Ironically, the shorts may feel 3.99 was as good as it
will get for them. And they may fear they have missed
out on their big chance to exit their very successful
crushing of the longs.
Time will tell.
The SPA will Result in Early FDA Approval
Because OCATs RPE Therapy, IS NOT A DRUG !
Depending on how the SPA is designed, it really
amounts to a method for the FDA to accommodate
the fact that RPE therapy is not actually a drug.
Things seem like they're moving slowly. But it's
actually the opposite. It's because phase 1 was
such an absolute slam-dunk. It's almost unheard
of to get safety and efficacy, right out of the gate.
The SPA is a way to wrap this thing up.
I can't think of any drug, or anything really, where
once it's administered or performed, and 30 days later
you're cured !
Not healing, not recovering, but CURED !
This is an absolute wonder !
And a new era, in medicine.
This so overshadows petty talk about funding.
All the petty criticisms melt to zero now,
absolute zero.
The SPA is like two cymbals crashing together,
ten times in a row, just like phase 1.
And to think that this is an out patient procedure,
that takes maybe an hour. They should hire a
cymbal player to greet every patient as they exit
the clinic after treatment.
OCAT has isolated a new adipose cell type.
I've heard a rumor that this will be mentioned
at today's CC at 4:30pm.
They've found an adipose cell with muscle fibers
that cannot be separated without destroying the
cell. They're not sure of the purpose just yet.
But they think it's highly and very important.
It has a complete set of genetic dna blueprints
to make a complete human being. So they are
proceeding with great caution and dignity.
They're informally calling this cell a kind of 'human bacon'.
And some in the the lab are hoping to one day
combine it with hESCs to further the science into
greater and as yet unproven realms, and produce
a fusion of delight that will satisfy all consumers.
I've heard rumors that this will be announced at
today's CC. There is great anticipation of this.
We should get a little pop in market cap, but we'll
have to wait and see. I'm hoping, I'm really hoping.
I Guess the 25% Short Position Does Matter.
25% of the float is shorted. I think this is
scaring new buyers away.
No fun giving it all back, is it?
Crude Tried To Rally And Failed
When the last crude oil storage facility is full,
crude will collapse again. We're almost there.
I mention this because I think this will buoy
the markets, the other markets.
ONVO, however is nasty, and getting nastier.
Down 24% from Thursday. If it's going to cut
itself in half on this move, that will put it at $3.50
or so. Ouch.
ONVO, needed to get ahead of the sentiment
by showing genuine good news, and they didn't.
I think this news exists already, but it's too late
now. The horses are out of the barn and they
each ran in a different direction. It's going to
take a while to recover these ponies.
Pity. Dead money in a bull market. The shorts
probably can look at their screens and see which
priced shares were bought when, and they can
punish the share price until people sell or the
story is good enough to turn things around.
People who bought at $8 to $13.65 need to
capitulate, or the story needs to improve.
Yesterday's plunge may have been EuroPeople Bailing Out.
The euro seems to be crashing.
I hate to talk about any single day. It makes me feel dirty
for some reason.
But, never the less, traders dump their good positions when
everything is crashing around them.
Shorts were reported yesterday.
now at 16.5 Million, down 1M from 17.6
Don't Forget, We're at the Very Beginning
of OCAT's technology for curing blindness. As
time moves forward, the RPE therapy will undoubtedly
be refined, and become more and more effective.
People who look at the world through fear goggles,
will always be on the outside of this type of
achievement. They never see what's right in front
of them. They're always looking over their shoulder
for this threat or that, this conspiracy or that.
It's their nature.
OCAT, once the RPE Therapy lights the fire, will
then introduce all the other cell therapies for
the other components of the eye.
And when this is complete, you will be able to
justly say that OCAT has 'cured' blindness.
Stem cells were discovered in 1998, and just
20 years later Ocata is introducing a curative
therapy for blindness.
This is a remarkably short period of time.
I admire this achievement. Because I admire
achievement in general.
None of this will move the stock, however.
The stock will do whatever it wants to do.
But, I watch each new press conference, and
each new 8k release, with excited anticipation
for newer and even greater news.
Looks like it's going_down to 3 or 4
That might be a resistance area looking at the chart.
The move from 2012 to 2013 was so rapid that clear
resistance areas didn't really form.
So, it could potentially, give it all back, right down to
a dollar or pennies.
One thing that hasn't happened since november 2013,
is a rally. That would be a surprise.
What a nasty plunge, and just before earnings
were susposed to be coming. Pity.
60 Million Dollars is_a Piddling, For_What's_Happening_Here
$6 looks like a hard deck.
The pulling of the stock offering,
and the somewhat strange silence about it,
says to me that there's a likelihood of some
type of private equity deal going on here.
Private equity deals are all the rage now.
So let's all rage about it!
I want to buy OCAT cheaper than $6,
and those bad, bad, capitalists won't let me!
Boo! Boo, hoo, hoo.
Spend 60M for a $20B +market, a piddling.
Not to mention the Nobel science,
Not to mention solving blindness.
Dow's Up 0.9%, ND 0.35%, SP 0.51% (bigly_huh?)
There's a lot of red out there.
I expect ONVO to rally from today.
Nothing will surprise me though.
It's been a tough 18 months.
At least there's basketball. Thank goodness
for March Madness. Watch ESPN now works
for directv subscribers. There's that.
I_can't remember_a_time_when a gap didn't get filled.
You either have to have strong nerves for this,
or a fine healthy liver.
OCAT is NOT Diluting
Let's look at some facts.
Post 100:1 Reverse Split 27 Aug 2014
Share Count: 34,393,658
Today Post Phase 1, 9 Mar 2015
Share Count: 34,617,718
A 7 Month Period, and dilution of 224,060 !
It was 34M then, it's still 34M now.
Dilution is now delusion, myth, and nonsense.
OCAT is in a new era.
OCAT is:
POST-Successful Reverse Split
POST-Successful Phase 1
POST-Successful NSDQ Up List
This is Ocata's track record.
To imagine or believe that Ocata will not
be able to raise money in an undiluted way,
is to not understand these three things.
I didn't even mention the
New Great Management Team,
The Clever Name Change,
and The Brilliant New Logo,
that's obvious to gamers what it represents,
and actually is the cleverest of all the new touches.
And don't forget about the blind people from phase 1,
who now have one good eye !!!
The meaning of Ocata's accomplishments,
and all of the fine people who made it happen,
is trying to be subverted.
OCAT is the 'first' to show successful cell therapy transplants.
This is Nobel prize level achievement. Read about it
in the October 2014 Lancet article yourself.
Time will tell. And not that much time, either.
Every surprise, from here forward, will
be to the upside. And it is no surprise.
GL Ocata, GL Longs
There are no negatives to OCAT RPE now.
Phase 1 -Success
NSDQ -Success
Clean Balance Sheet
No Debt
No Dilution
It's VERY doubtful they won't find non-dilutive
funding with the above factors.
It might seem risky to test for deletion of
the immunosuppression drug requirement.
But perhaps these drugs have unpleasant
side effects, and the time spent will be
worth the risk for the comfort of not using them.
And the time spent will be recovered when phase 2
begins.
In any case, you can always go back to using them
if any problems arise.
So, there are no negatives to OCAT RPE.
People said OCAT RPE would never up list -Wrong
People said OCAT RPE would plunge from dilution -Wrong
The naysayers are continually moving their goal posts.
And are forced into simple minded criticisms from
the time before phase 1 completion.
The share price is holding steady near the $6 level,
and it looks very much like some sort of accumulation
algorithm is running. It's only a matter of time now,
not if !
http://shortvolume.com/
enter ONVO
5 Day Scale
It was about 4 to 1 by eyeball
I guess it was 4X higher
The Story Doesn't Get Much Better Than ONVO.
ONVO has the liver test strips that we all know about.
And the conference mentions how a drug can be
introduced to the test strip and it will indicate toxicity
in two different ways. As far as I'm concerned, why
would you even bother with mice if this is available?
This has to affect drug development costs.
And the second and new thing I learned about are
the spherical cancer tumor balls for testing if a
cancer drug will penetrate a tumor and be effective.
So, first quarter 10Q is the first week of May,
and second quarter August, we should see the profit
needle come off the stop, at least a little.
Shorts interest were triple yesterday. So the shorts are
in charge for now. By year end these guys will be buried
if they're still here. I hope I live to see that.
Little Livers and Little Cancer Balls, Kidney-Standby.
Recent ONVO Conference Presentation
http://virtualinvestorconferences.com/
t's So Easy to_Look Backwards And Make Predictions
But where are we?
Phase 1 -Success
Nasdq -Success
It's only March, 2015.
The RPE Cell Therapy Works!
No one can take this away. They can disrespect it,
they can bad mouth it, but they can't touch it.
Because it works!
The future will come. And when it does Ocata will
be there with their cell therapy. And it will be worth
more than now.
The gap is at 5.50, once it's filled
the stock can takeoff. I know it's wierd,
but I've seen this many times.
Why doesn't the chart work, up above?
Is shutting off the chart some subtle gouge
at this company by some 'honest broker' moderator?
Remember the pics from cracked.com?
Pretending that Cell Therapy is_a Drug is Stupid.
The FDA has to spin their wheels, because that's all they
know how to do.
But really, do we have to play along like blind mice?
Injecting living RPE cells is in no way like a drug of any sort.
Once the phase 2 patients are injected. It's all over.
BECAUSE THEY WILL BE ABLE TO SEE.
It's what's already happened in phase 1.
The pretending needs to stop.
Big Pharma is Toast. The_Days_of_Selling_Poision_Are_Over.
Phase 1 -Complete
NASDQ -Complete
When the market begins to understand, OCAT will
rise in billion dollar increments of market cap.
Cellular medicine is a new dawn.
In 6 months the phase 2 data will trickle in,
the market will move before that.
This is a new branch of science and medicine.
And Ocata has the IP to go it alone. They have
$20 million, and they've made it clear that they
only needed $40 million for their next phase 2.
They can begin and get well into it with what they
have already.
Without doing, ANYTHING
Used ToGet A BuckOrTwo OutOf A Positive Article
Now it looks like nothing will come of it, at all.
This company needs to release all positives.
And get inside the decision cycle of the shorts.
Start throwing fast balls every pitch.
It needs to walk the walk.
The talk just isn't getting it done.
Any discussion of printing human organs immediately
changes the focus to a decade or more in the future.
The FDA process take ten years, AFTER they actually
print an organ.
They need to change the entire focus of the company
from 3D printing to diagnostic biotechnology.
It's time to stop with the nerd fantasy and focus on bucks.
And the money ball is toxicity testing.